NAOMI HEFRIGHT: Open Payments
NPI 1225738214 · DU BOIS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,743 in 187 payments from 19 companies in 2025. Trend: 2023 $1,478 · 2024 $4,642 · 2025 $3,743
Food & beverage: $3,631Education: $81Speaker / faculty: $31
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $531 |
| Neurocrine BioSciences, Inc. | 10 | $369 |
| ACADIA Pharmaceuticals Inc | 12 | $352 |
| Teva Pharmaceuticals USA, Inc. | 22 | $314 |
| MDD US Operations, LLC | 9 | $312 |
| Biogen, Inc. | 15 | $280 |
| Lundbeck LLC | 20 | $224 |
| Genentech USA, Inc. | 11 | $207 |
| UCB, Inc. | 10 | $204 |
| Axsome Therapeutics, Inc. | 4 | $179 |
Products named: INGREZZA, NUPLAZID, AUSTEDO XR, VYEPTI, BOTOX, TYSABRI, QULIPTA, Symbravo.
Industry payments across PA — which companies pay providers there.
